Unknown PHASE2/PHASE3 INTERVENTIONAL NCT00370734

Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease

Sponsor: Shahid Beheshti University of Medical Sciences

Interventions Botulinum toxin A injection

Updated 6 times since 2017 Last updated: Feb 26, 2007 Started: May 31, 2005 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Eye Diseases and is currently ongoing. Shahid Beheshti University of Medical Sciences leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shahid Beheshti University of Medical Sciences

Data source: Shahid Beheshti University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran